Monday - February 2, 2026
HKUMed develops novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
January 26, 2026
HONG KONG, Jan. 26 -- The University of Hong Kong issued the following news release:

* * *

HKUMed develops novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose

*

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products